NCT02731040View on ClinicalTrials.gov

Exome Sequencing for Atypical Femoral Fractures

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions
Atypical Femoral FracturesOsteoporosisBisphosphonate Therapy
Interventions
DRUG

Bisphosphonate

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT02731040 - Exome Sequencing for Atypical Femoral Fractures | Biotech Hunter | Biotech Hunter